Recursion Pharmaceuticals Inc (RXRX)
8.26
-0.61
(-6.88%)
USD |
NASDAQ |
May 31, 16:00
8.36
+0.10
(+1.21%)
After-Hours: 20:00
Recursion Pharmaceuticals Profit Margin (Quarterly): -677.3% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -677.3% |
December 31, 2023 | -875.3% |
September 30, 2023 | -920.8% |
June 30, 2023 | -696.5% |
March 31, 2023 | -538.4% |
December 31, 2022 | -420.4% |
September 30, 2022 | -463.1% |
June 30, 2022 | -856.7% |
Date | Value |
---|---|
March 31, 2022 | -1.06K% |
December 31, 2021 | -2.60K% |
September 30, 2021 | -1.90K% |
June 30, 2021 | -1.74K% |
March 31, 2021 | -1.23K% |
December 31, 2020 | -1.01K% |
September 30, 2020 | -2.77K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-2.77K%
Minimum
Sep 2020
-420.4%
Maximum
Dec 2022
-1.18K%
Average
-920.8%
Median
Sep 2023
Profit Margin (Quarterly) Benchmarks
Eli Lilly and Co | 25.58% |
Viking Therapeutics Inc | -- |
Actinium Pharmaceuticals Inc | -- |
Macrogenics Inc | -573.3% |
Marinus Pharmaceuticals Inc | -503.6% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -80.42% |
Return on Assets | -56.45% |
Return on Invested Capital | -80.14% |
Gross Profit Margin (Quarterly) | 17.23% |
Operating Margin (Quarterly) | -714.1% |
Return on Net Operating Assets | -177.5% |